HYPERFINE INC CLASS A (HYPR) — insider trading
Health Care · NASDAQ
HYPERFINE INC CLASS A (HYPR) has 12 reported SEC Form 4 insider transactions in our data, including 4 open-market sales among the most recent 12 (latest 2026-06-03).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | Wolterman Dan | Director | Grant / award / vesting (derivative) | 52,600 | $0.00 | $0 | Form 4 |
| 2026-05-26 | TEISSEYRE THOMAS | Officer (Chief Operating Officer) | Open-market sale | 6,047 | $1.65 | $10.0K | Form 4 |
| 2026-05-26 | HALE BRETT | Officer (CFO and CAO) | Open-market sale | 6,047 | $1.65 | $10.0K | Form 4 |
| 2026-05-22 | ROTHBERG JONATHAN M | Director, 10% owner | Grant / award / vesting (derivative) | 157,700 | $0.00 | $0 | Form 4 |
| 2026-05-22 | Dahldorf John T | Director | Grant / award / vesting (derivative) | 157,700 | $0.00 | $0 | Form 4 |
| 2026-05-22 | Wolterman Dan | Director | Grant / award / vesting (derivative) | 157,700 | $0.00 | $0 | Form 4 |
| 2026-05-22 | Fattori Ruth A | Director | Grant / award / vesting (derivative) | 157,700 | $0.00 | $0 | Form 4 |
| 2026-03-31 | Sainz Maria | Director, Officer (President and CEO) | Grant / award / vesting | 750,000 | $0.00 | $0 | Form 4 |
| 2026-03-31 | TEISSEYRE THOMAS | Officer (Chief Operating Officer) | Grant / award / vesting | 330,000 | $0.00 | $0 | Form 4 |
| 2026-03-31 | HALE BRETT | Officer (CFO and CAO) | Grant / award / vesting | 330,000 | $0.00 | $0 | Form 4 |
| 2026-03-23 | HALE BRETT | Officer (CFO and CAO) | Open-market sale | 24,188 | $1.21 | $29.3K | Form 4 |
| 2026-03-23 | TEISSEYRE THOMAS | Officer (Chief Operating Officer) | Open-market sale | 24,188 | $1.21 | $29.3K | Form 4 |
Ask the chat about HYPR's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: HYPERFINE INC CLASS A (HYPR).
Last updated 2026-06-03 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.